One of the most direct reason for the failure of PD‐1/PD‐L1 antibody to treat tumors (primary or secondary drug resistance) is the lack of high immunogenicity tumor‐specific antigen, leading to the failure of T cells to recognize it. The gene discussed is PDCD1; the disease is neoplasm.